Hepatic 31P MRS in rat models of chronic liver disease

Assessing the extent and progression of disease

I. R. Corbin, R. Buist, J. Peeling, M. Zhang, J. Uhanova, G. Y. Minuk

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Background: Hepatic adenosine triphosphate (ATP) levels are an accurate reflection of functioning hepatic mass following surgical resections and acute liver injury. Objective: To determine whether hepatic ATP levels can serve as a non-invasive means of documenting progression of chronic liver disease to cirrhosis. Methods: In vivo phosphorus-31 magnetic resonance spectroscopy (31P MRS) was performed in three animal models of chronic liver disease. Sixty six adult Sprague- Dawley rats were subjected to either thioacetamide, carbon tetrachloride (CCl4), or common bile duct ligation (CBDL) to induce liver disease (n=35, 21, and 10, respectively). Serial MRS examinations, blood samples, and liver biopsies (when appropriate) were obtained throughout and/or on completion of the study. Results: Over the course of the chronic liver disease, a progressive decrease in hepatic ATP levels was consistently observed in each model. The findings were most striking when end stage liver disease (cirrhosis) was established. The reduction in hepatic ATP levels correlated with significant changes in serum albumin concentrations (CCl4 and CBDL models) and the extent of hepatocyte loss seen histologically (all models). Conclusion: The results of this study indicate that during progression bf chronic liver disease to cirrhosis, there is a progressive reduction in hepatic ATP levels. In addition, changes in hepatic ATP levels correlate with changes in liver function and histology. Thus hepatic 31P MRS provides a non-invasive means of documenting the severity and progression of parenchymal and cholestatic models of chronic liver disease in rats.

Original languageEnglish (US)
Pages (from-to)1046-1053
Number of pages8
JournalGut
Volume52
Issue number7
DOIs
StatePublished - Jul 1 2003

Fingerprint

Disease Progression
Liver Diseases
Chronic Disease
Liver
Adenosine Triphosphate
Common Bile Duct
Ligation
Fibrosis
Thioacetamide
End Stage Liver Disease
Carbon Tetrachloride
Serum Albumin
Liver Cirrhosis
Phosphorus
Sprague Dawley Rats
Hepatocytes
Histology
Magnetic Resonance Spectroscopy
Animal Models
Biopsy

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Hepatic 31P MRS in rat models of chronic liver disease : Assessing the extent and progression of disease. / Corbin, I. R.; Buist, R.; Peeling, J.; Zhang, M.; Uhanova, J.; Minuk, G. Y.

In: Gut, Vol. 52, No. 7, 01.07.2003, p. 1046-1053.

Research output: Contribution to journalArticle

Corbin, I. R. ; Buist, R. ; Peeling, J. ; Zhang, M. ; Uhanova, J. ; Minuk, G. Y. / Hepatic 31P MRS in rat models of chronic liver disease : Assessing the extent and progression of disease. In: Gut. 2003 ; Vol. 52, No. 7. pp. 1046-1053.
@article{7f5916177ccc41d4b551cd30aa1ee6c6,
title = "Hepatic 31P MRS in rat models of chronic liver disease: Assessing the extent and progression of disease",
abstract = "Background: Hepatic adenosine triphosphate (ATP) levels are an accurate reflection of functioning hepatic mass following surgical resections and acute liver injury. Objective: To determine whether hepatic ATP levels can serve as a non-invasive means of documenting progression of chronic liver disease to cirrhosis. Methods: In vivo phosphorus-31 magnetic resonance spectroscopy (31P MRS) was performed in three animal models of chronic liver disease. Sixty six adult Sprague- Dawley rats were subjected to either thioacetamide, carbon tetrachloride (CCl4), or common bile duct ligation (CBDL) to induce liver disease (n=35, 21, and 10, respectively). Serial MRS examinations, blood samples, and liver biopsies (when appropriate) were obtained throughout and/or on completion of the study. Results: Over the course of the chronic liver disease, a progressive decrease in hepatic ATP levels was consistently observed in each model. The findings were most striking when end stage liver disease (cirrhosis) was established. The reduction in hepatic ATP levels correlated with significant changes in serum albumin concentrations (CCl4 and CBDL models) and the extent of hepatocyte loss seen histologically (all models). Conclusion: The results of this study indicate that during progression bf chronic liver disease to cirrhosis, there is a progressive reduction in hepatic ATP levels. In addition, changes in hepatic ATP levels correlate with changes in liver function and histology. Thus hepatic 31P MRS provides a non-invasive means of documenting the severity and progression of parenchymal and cholestatic models of chronic liver disease in rats.",
author = "Corbin, {I. R.} and R. Buist and J. Peeling and M. Zhang and J. Uhanova and Minuk, {G. Y.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1136/gut.52.7.1046",
language = "English (US)",
volume = "52",
pages = "1046--1053",
journal = "Gut",
issn = "0017-5749",
publisher = "BMJ Publishing Group",
number = "7",

}

TY - JOUR

T1 - Hepatic 31P MRS in rat models of chronic liver disease

T2 - Assessing the extent and progression of disease

AU - Corbin, I. R.

AU - Buist, R.

AU - Peeling, J.

AU - Zhang, M.

AU - Uhanova, J.

AU - Minuk, G. Y.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Background: Hepatic adenosine triphosphate (ATP) levels are an accurate reflection of functioning hepatic mass following surgical resections and acute liver injury. Objective: To determine whether hepatic ATP levels can serve as a non-invasive means of documenting progression of chronic liver disease to cirrhosis. Methods: In vivo phosphorus-31 magnetic resonance spectroscopy (31P MRS) was performed in three animal models of chronic liver disease. Sixty six adult Sprague- Dawley rats were subjected to either thioacetamide, carbon tetrachloride (CCl4), or common bile duct ligation (CBDL) to induce liver disease (n=35, 21, and 10, respectively). Serial MRS examinations, blood samples, and liver biopsies (when appropriate) were obtained throughout and/or on completion of the study. Results: Over the course of the chronic liver disease, a progressive decrease in hepatic ATP levels was consistently observed in each model. The findings were most striking when end stage liver disease (cirrhosis) was established. The reduction in hepatic ATP levels correlated with significant changes in serum albumin concentrations (CCl4 and CBDL models) and the extent of hepatocyte loss seen histologically (all models). Conclusion: The results of this study indicate that during progression bf chronic liver disease to cirrhosis, there is a progressive reduction in hepatic ATP levels. In addition, changes in hepatic ATP levels correlate with changes in liver function and histology. Thus hepatic 31P MRS provides a non-invasive means of documenting the severity and progression of parenchymal and cholestatic models of chronic liver disease in rats.

AB - Background: Hepatic adenosine triphosphate (ATP) levels are an accurate reflection of functioning hepatic mass following surgical resections and acute liver injury. Objective: To determine whether hepatic ATP levels can serve as a non-invasive means of documenting progression of chronic liver disease to cirrhosis. Methods: In vivo phosphorus-31 magnetic resonance spectroscopy (31P MRS) was performed in three animal models of chronic liver disease. Sixty six adult Sprague- Dawley rats were subjected to either thioacetamide, carbon tetrachloride (CCl4), or common bile duct ligation (CBDL) to induce liver disease (n=35, 21, and 10, respectively). Serial MRS examinations, blood samples, and liver biopsies (when appropriate) were obtained throughout and/or on completion of the study. Results: Over the course of the chronic liver disease, a progressive decrease in hepatic ATP levels was consistently observed in each model. The findings were most striking when end stage liver disease (cirrhosis) was established. The reduction in hepatic ATP levels correlated with significant changes in serum albumin concentrations (CCl4 and CBDL models) and the extent of hepatocyte loss seen histologically (all models). Conclusion: The results of this study indicate that during progression bf chronic liver disease to cirrhosis, there is a progressive reduction in hepatic ATP levels. In addition, changes in hepatic ATP levels correlate with changes in liver function and histology. Thus hepatic 31P MRS provides a non-invasive means of documenting the severity and progression of parenchymal and cholestatic models of chronic liver disease in rats.

UR - http://www.scopus.com/inward/record.url?scp=0037784080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037784080&partnerID=8YFLogxK

U2 - 10.1136/gut.52.7.1046

DO - 10.1136/gut.52.7.1046

M3 - Article

VL - 52

SP - 1046

EP - 1053

JO - Gut

JF - Gut

SN - 0017-5749

IS - 7

ER -